Bruce F. Wesson, Director at ACURA PHARMACEUTICALS, INC (ACUR), bought 60,000 shares at $1.12 ($68K) on 2014-05-15, disclosed to the SEC on 2014-05-16.
Open-market purchase of $68k ACUR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.11 | 10,000 | $11K | 16.3% |
| 2 | $1.12 | 10,000 | $11K | 16.4% |
| 3 | $1.12 | 20,000 | $22K | 32.8% |
| 4 | $1.17 | 10,100 | $12K | 17.3% |
| 5 | $1.18 | 9,900 | $12K | 17.1% |
| Total | $1.14 avg | 60,000 |
| $68K |
| 100% |
| Filing → |
| MDAS | SELL | 2013-11-22 | $1.2M | — | Filing → |
| MDAS | BUY | 2011-11-28 | $225K | — | Filing → |
| DSCI | BUY | 2011-11-28 | $75K | — | Filing → |